Join Jon and Pete Najarian on today's episode of Rebel's Edge as they discuss stocks including Goldman Sach's surging profits, Encore Wire getting bought out, Medical Properties Trust unloading some hospitals, and Neumora Therapeutics having a phase 1 trial halted by the FDA. Gain a deeper understanding of these stocks as Jon and Pete share their perspectives, potential growth prospects, and market predictions. They also talk about the Masters ratings and Tom Brady teasing a return to the field. Stay on the cutting edge with Rebel's Edge.